NCT01767558View on ClinicalTrials.gov

PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Atrial Fibrillation
Interventions
OTHER

Ablation / MRI

"All subjects will undergo a standard of care ablation procedure for paroxysmal AF with the CE-Marked PVAC GOLD catheter.~MRIs will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at Pre-Discharge will undergo another MRI at the 1 month follow-up visit."

Trial Locations (11)

Unknown

ZNA Middelheim, Antwerp

Hopital Cardiolgique du Haut-Leveque, Pessac

Zentraklinik Bad Berka, Bad Berka

St. Agnes Hospital Bocholt, Bocholt

Zentrum fuer klinische Pruefungen in der Facharztzentrum Dresden-Neustadt GbR, Dresden

Debrecen University, Debrecen

Catharina Hospital, Eindhoven

St. Antonius Hospital, Nieuwegein

Eastbourne District General Hospital, Eastbourne

University Hospital of South Manchester, Manchester

Freeman Hospital, Newcastle upon Tyne

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01767558 - PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD) | Biotech Hunter | Biotech Hunter